Document Detail


Centrally administered insulin potentiates the pressor response to angiotensin II.
MedLine Citation:
PMID:  20433878     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim of the present study was to determine if insulin can modulate the pressor response to angiotensin II at brain level in normotensive rats. Anaesthetized male rats were intracerebroventricularly infused with insulin (12 mU/h, n=15) or Ringer's solution as vehicle (n=15) for 2 h. Immediately, changes in mean arterial pressure (MAP) in response to an intracerebroventricular subpressor dose of angiotensin II (5 pmol, n=10) or vehicle (n=5) were measured for 10 min. Then, hypothalami were removed and Akt and ERK1/2 phosphorylation levels were determined. In other subset of animals, PD98059 (MAPK inhibitor) or vehicle were intracerebroventricularly administered previously to insulin perfusion for 2 h and changes in MAP in response to intracerebroventricular angiotensin II (5 pmol) injection were evaluated for 10 min (n=6 for each group). Angiotensin II did not modify MAP in vehicle pre-treated rats, but increased MAP in insulin pre-treated animals. Insulin significantly increased Akt phosphorylation, but no changes were observed after angiotensin II injection in vehicle-pretreated animals. Angiotensin II or insulin infusion increased in more than two fold phospho-ERK 1/2 hypothalamic levels. Animals that received insulin infusion followed by Ang II injection presented 4.5 higher values than those which received vehicle, and nearly twice than those who received Ang II without insulin pre-treatment. PD98059 administration abolished the blood pressure response exerted by angiotensin II in insulin pre-treated rats. In conclusion, centrally administered insulin potentiates the pressor effects to angiotensin II, suggesting a novel mechanism, possibly involving MAPK activation, by which insulin influences blood pressure control at central level.
Authors:
Marcos A Mayer; Jorge F Giani; Christian Höcht; Ezequiel A Silberman; Marina C Muñoz; Carlos A Taira; Fernando P Dominici; Ana M Puyó; Belisario E Fernández
Related Documents :
8214048 - Regulation of glucose transporter and hexokinase ii expression in tissues of diabetic r...
10428828 - Hexokinase ii-deficient mice. prenatal death of homozygotes without disturbances in glu...
3929668 - C-peptide response in patients on insulin therapy.
15630048 - Effects of angiotensin type-1 receptor antagonism on small artery function in patients ...
11375798 - Coronary artery disease risk in chinese type 2 diabetics: is there a role for paraxonas...
16732008 - Clinical evaluation of alternative-site glucose measurements in patients after major ca...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-04-28
Journal Detail:
Title:  Regulatory peptides     Volume:  163     ISSN:  1873-1686     ISO Abbreviation:  Regul. Pept.     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-07-12     Completed Date:  2011-01-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8100479     Medline TA:  Regul Pept     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  57-61     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2010 Elsevier B.V. All rights reserved.
Affiliation:
Department of Anatomy and Histology, University of Buenos Aires, Junin 956, (C1113AAD), Buenos Aires, Argentina. marcos.mayer@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin II / administration & dosage,  antagonists & inhibitors,  pharmacology*
Animals
Blood Pressure / drug effects*
Flavonoids / pharmacology
Insulin / administration & dosage*,  pharmacology*
Male
Mitogen-Activated Protein Kinases / antagonists & inhibitors,  metabolism
Rats
Rats, Sprague-Dawley
Chemical
Reg. No./Substance:
0/Flavonoids; 0/PD 98059; 11061-68-0/Insulin; 11128-99-7/Angiotensin II; EC 2.7.11.24/Mitogen-Activated Protein Kinases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Glucose-dependent insulinotropic polypeptide stimulates the proliferation of colorectal cancer cells...
Next Document:  gp-91 mediates histone deacetylase inhibition-induced cardioprotection.